PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
18-Mar-2023 HKSTP's Global Talent Mission Hits Top Gear with “Gamified Career Journey in Live” Event and Hong Kong’s Largest I&T Career Expo Kick-Off Businesswire
18-Mar-2023 Takeda Announces Positive Results in Phase 2b Study of Investigational TAK-279, an Oral, Once-Daily TYK2 Inhibitor, in People with Moderate-to-Severe Plaque Psoriasis Businesswire
18-Mar-2023 Celyad Oncology to Announce Full Year 2022 Financial Results and Host Conference Call Businesswire
17-Mar-2023 Scailyte Announces Collaboration With Turnstone Biologics to Identify Biomarker Signatures in Solid Tumors With TIL Therapy Newswire
17-Mar-2023 Number of Shares and Voting Rights of ADOCIA as of February 28th, 2023 Businesswire
17-Mar-2023 Rhythmlink Announces Investment Partnership With Graham Partners Businesswire
17-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Marathon Digital Holdings, Inc. (MARA) on Behalf of Investors Businesswire
17-Mar-2023 Kuria Therapeutics Completes FDA Pre-IND Consultation for Topical Nrf2 Activator for Corneal Endothelial Disease Businesswire
17-Mar-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
17-Mar-2023 Eluceda Develops ‘Two-Minute’ Covid Vaccine Authentication Test Eluceda
17-Mar-2023 Yamaha Motor Continues Commitment to Reduce Carbon Footprint with Investment in Andes, a CO2 Removal Biotechnology Startup Businesswire
17-Mar-2023 Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update Businesswire
17-Mar-2023 Global LAG-3 Inhibitor Market, Drug Sales, Price & Clinical Trials Insights Report 2023-2028: One of the Most Studied Immune Checkpoint After PD-1 and CTLA-4 - ResearchAndMarkets.com Businesswire
17-Mar-2023 TWIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Twist Bioscience Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm Businesswire
17-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Allbirds, Inc. (BIRD) on Behalf of Investors Businesswire
17-Mar-2023 Matrivax Initiates Phase 1 Clinical Development of MVX01, a Novel Pneumococcal Vaccine Candidate Businesswire
16-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of LivePerson, Inc. (LPSN) on Behalf of Investors Businesswire
16-Mar-2023 JATT Acquisition Corp Shareholders Approve Proposed Business Combination with Zura Bio Limited Businesswire
16-Mar-2023 Kodak Reports Fourth-Quarter and Full-Year 2022 Financial Results Businesswire
16-Mar-2023 Merck Provides Update from Open-Label Arm of Phase 2 KeyVibe-002 Trial Evaluating MK-7684A, a Coformulation of Vibostolimab and Pembrolizumab, in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) Businesswire